Literature DB >> 31532699

Optimization of Oxygen Dynamics, UV-A Delivery, and Drug Formulation for Accelerated Epi-On Corneal Crosslinking.

Jason Hill1, Cailing Liu1, Phillip Deardorff1, Behrouz Tavakol1, William Eddington1, Vance Thompson2, Dan Gore3, Michael Raizman4, Desmond C Adler1.   

Abstract

Purpose: Corneal collagen crosslinking (CXL) through an intact epithelium (epi-on) at high irradiance could potentially improve patient comfort, visual recovery, and clinical workflow compared to conventional epi-off CXL. However, intact epithelium limits stromal delivery of the oxygen, photosensitizer, and ultraviolet-A (UV-A) radiation needed to drive CXL. This ex vivo study evaluated three different epi-on CXL protocols compared to positive and negative controls, specifically focusing on the impact of supplemental oxygen. Endpoints included stromal oxygen levels, stiffness of crosslinked tissue, and acute flattening of whole eyes.Materials &
Methods: Ex vivo porcine eyes were held in a custom environmental chamber. Intrastromal oxygen levels were continuously measured before, during, and after UV illumination by a fiberoptic probe inserted into a laser-cut flap. Accelerated, high irradiance, epi-on CXL protocols using riboflavin formulated with benzalkonium chloride (BAC) were studied, with and without supplemental oxygen. These were compared to an alternate, low irradiance, epi-on protocol using riboflavin formulated with sodium iodide. Both negative (no CXL) and positive (epi-off modified Dresden protocol) controls were performed. Post-CXL elastic modulus was measured using extensiometry and anterior tangential curvature was measured using a Scheimpflug tomographer.
Results: Protocols including supplemental oxygen resulted in an approximately 5-fold increase in stromal oxygen levels prior to CXL. During epi-on, high-irradiance UV-A delivery under hyperoxic conditions, an aerobic state was maintained. Conversely, under normoxic conditions, stromal oxygen rapidly depleted to 0-5% for all other protocols. The combination of supplemental oxygen, BAC formulation, and high-irradiance UV-A resulted in the largest biomechanical changes and most pronounced flattening effects of the three epi-on protocols.Conclusions: Ex vivo analysis of stromal oxygen levels, corneal stiffness, and acute anterior curvature change indicates that simultaneous optimization of the oxygen environment, riboflavin formulation, and UV-A protocol can significantly increase the effects of corneal collagen crosslinking.

Entities:  

Keywords:  Crosslinking; corneal ectasia; keratoconus; oxygen

Mesh:

Substances:

Year:  2019        PMID: 31532699     DOI: 10.1080/02713683.2019.1669663

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

Review 1.  New perspectives in keratoconus treatment: an update on iontophoresis-assisted corneal collagen crosslinking.

Authors:  Paolo Vinciguerra; Alessio Montericcio; Fiammetta Catania; Giovanni Fossati; Raffaele Raimondi; Emanuela Filomena Legrottaglie; Riccardo Vinciguerra
Journal:  Int Ophthalmol       Date:  2021-02-16       Impact factor: 2.031

2.  Enrichment of Oxygen Concentration Over Simulated Corneal Surface Through Noncontact Oxygen Delivery Device.

Authors:  Omkar C Thaware; David Huang
Journal:  J Refract Surg       Date:  2020-09-01       Impact factor: 3.573

Review 3.  [Treatment indications for corneal crosslinking and clinical results of new corneal crosslinking techniques].

Authors:  Klara Borgardts; Johannes Menzel-Severing; Gerd Geerling; Theo G Seiler
Journal:  Ophthalmologe       Date:  2022-02-11       Impact factor: 1.059

4.  The efficiency and safety of oxygen-supplemented accelerated transepithelial corneal cross-linking.

Authors:  Emre Aydın; Mehmet Gökhan Aslan
Journal:  Int Ophthalmol       Date:  2021-04-19       Impact factor: 2.031

5.  Corneal Crosslinking in Refractive Corrections.

Authors:  Viral V Juthani; Roy S Chuck
Journal:  Transl Vis Sci Technol       Date:  2021-04-29       Impact factor: 3.283

6.  Epithelium-on Corneal Collagen Cross-Linking with Hypotonic Riboflavin Solution in Progressive Keratoconus.

Authors:  Kenneth A Beckman
Journal:  Clin Ophthalmol       Date:  2021-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.